The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Obagi Medical Products Inc.  (OMPI) Trade Now »     Rate OMPI  -  Discuss OMPI  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate OMPI:



OMPI Analysis & Videos »


OMPI: Bull or Bear?

Obagi Medical Products Inc. Graphic_rating_sell OMPI
Foto
62%
 -75.41%
in 248 days
(closed on 01/11/10)
Obagi Medical Products Reports First Quarter 2009 Financial Results Thursday, May 07, 2009 4:05:08 PM ET Obagi Medical Products, Inc. (OMPI ), a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the first quarter ended March 31, 2009. Net sales were $22.6 million, compared with $25.4 million in the first quarter of 2008. Obagi’s sales in the first quarter of 2009 include a strong reception to the newly launched Obagi(R) Rosaclear(TM) System, which is the first prescription-based physician-dispensed system developed specifically for...
By  Marian Filo   (-24.55%  risk: aggressive)  05/08/09 2 comments


In Search of Healthcare Diamonds in the Rough Graphic_rating_buy OMPI
Mikerun
73%
 +78.88%
in 1239 days

In Search of Healthcare Diamonds in the Rough

<> While we are not even halfway through January, the healthcare sector is already active with deal-making, ranging from the rumored $95 buyout of biotech giant Genetech (DNA) by Roche (RHHBY) to Endo's (ENDP) purchase of small-cap, specialty pharma Indevus (IDEV) to Sequenom's (SQNM) $41M offer for emerging diagnostic company EXACT Sciences (EXAS) – which was promptly rebuffed by EXACT's board after the market close on Monday on the promise of a better deal in the works for shareholders.

Larger bio-pharma and diagnost...
By  Mike Havrilla   (+1.04%  risk: moderate)  01/13/09 1 comment


lucrative field Graphic_rating_buy OMPI
35%
 -13.76%
in 1856 days
Obagi works in skin care focusing on skin damage, wrinkles, pre-mature aging, sun damage, etc. The fundamentals are pretty good and this product line is all over beauty magazines. With the increased global temperatures and no decrease in sun bathing leads to many people with wrinkles and skin damage. This will be a huge field in the future. A good value stock to buy and hold for the next 5-10 years.
By  Rjcasey   (-7.24%  risk: aggressive)  05/06/07 2 comments


Get free stock alert for OMPI:
Your Email Address:





People Bullish on OMPI

450vampyr_avatar-med
supratrader
Principal
N/A
over 2 years ago

Foto
Marian Filo
Principal
62%
over 2 years ago

greensbr
Analyst
N/A
over 3 years ago

Mikerun
Mike Havrilla
Principal
73%
over 3 years ago

ralhan
Analyst
12%
over 4 years ago


People Bearish on OMPI

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.36% 531
2 Gerald Greene 18.14 +36.28% 286
3 stockmarketfunding.com 17.66 +23.07% 83
4 akiralegrand 13.47 +13.37% 69
5 anup2104 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment
AIG American International Group Inc.
EMC EMC Corp
WMT WalMart Stores Inc
TWX Time Warner Inc
SBUX Starbucks Corp
KO The CocaCola Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on OMPI


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Obagi Medical Products Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch